Connexin 43 (Cx43), a vital gap junction protein in tumor microenvironment (TME), is a novel molecular target for melanoma chemotherapeutics due to its tumor suppressive function. Dioscin, an herbal steroidal saponin, exerts anti-tumor effects while the underlying mechanism is unclear. Using WB, FACS, and immunofluorescence methodologies, we found dioscin significantly activated the transcription and translation of Cx43 via the retinoid acid signaling pathway and simultaneously enhanced the transporting function of Cx43. Through stimulating Cx43, dioscin remarkably suppressed the migratory and invasive capacities of B16 cells, and notably decreased pluripotency markers of cancer stem cells and epithelial-to-mesenchymal transition in B16 cells and animal tumor tissues. Conversely, dioscin improved the secretion of pro-inflammatory cytokines (IL-6, TNFa, and IL-1b), and the phagocytic capacity of tumor-associated macrophages by increasing M2-to-M1 phenotype transition. More strikingly, even in Cx43 functional deficient B16 and RAW264.7 cells, dioscin still dramatically reversed the aggravated tumor malignancy and reduced macrophage phagocytic activity. Two classical metastasis animal models were utilized in vivo and results showed that dioscin showed significant anti-metastatic effects, which is closely related to the expression of Cx43 either in in situ tumor or metastatic lung nodes. In conclusion, dioscin targets Cx43 to suppress the tumor cell malignancy and activate macrophage sensitivity, thereby targeting melanoma microenvironment.
Introduction
Melanoma is a common but highly aggressive skin malignancy that was estimated to lead 76,380 new cases and 10,130 mortalities within 2016 in the United States. 1 Even diagnosed at an early stage, melanoma cells can metastasize into multiple organs, [2] [3] [4] consequentially leading to poor prognosis and high mortality of melanoma patients. 5 Emerging evidence suggested that "extravascular metastasis," an alternative pathway for tumor cell spread that complements for "intravascular metastasis," is becoming increasingly significant in metastatic melanoma progression. 6 Tumor microenvironment, which is embedded in abluminal vascular surfaces, is critical for melanoma treatment and relapse prevention. 4 TME consists of tumor cells and surrounding nontumor components such as macrophages, fibroblasts, lymphocytes, cytokines, and extracellular matrix. Macrophages, critical players in TME, could be subclassified into M1 and M2 types. M1-macropahges are responsible for iNOS expression and secretion of proinflammatory factors such as IL-1b, TNF-a, and IL-6. M2-macrophages, which express CD206, 209 and release TGF-b, are considered as tumor associated macrophages (TAMs) and lead to poor outcome in melanoma.
tumor cells and surrounding immune cells, such as natural killer (NK) and dendritic cell (DC). 10 However, whether the function of Cx43 is associated with the recognition of tumor cells and macrophages in TME remains controversial. Cx43 downregulation suppress the phagocytic ability of TAMs, ultimately facilitating melanoma metastasis. 11 Conversely, Cx43 were previously classified as a tumor suppressor gene in tumor cells because of its diminished expression and dysfunction, [12] [13] [14] [15] as well as its anti-proliferative potentiality. 16, 17 In melanoma, the inhibition of Cx43-mediated communicational accelerates melanoma cell proliferation, whereas highly expressed Cx43 reduces cell growth. 18 Thus, upregulation of Cx43 is a plausible strategy for therapeutics in melanoma treatment. Furthermore, although TME has been recently proposed as a target of therapy, the exploration and development of corresponding chemopreventive agents has not received concerted efforts to date. Small molecular inhibitors (SMIs) such as BRAF V600 and MEK kinase inhibitors, as well as immune checkpoint blockers, such as PD-1 and CLTA-4 inhibitors, have achieved considerable clinical success. 19 Unfortunately, SMIs display inevitable disadvantages including rapidly acquire resistance and development of secondary cutaneous plasticity in advanced metastatic melanoma. 20 Importantly, none of these SMIs could exhibit anti-tumor effects and simultaneously activate immune response. Dioscin is a steroidal saponin extracted from the roots of Polygonatum zanlanscianense. 21 Dioscin induces tumor cell apoptosis in breast cancer through activating apoptosisinducing factor. 22 Dioscin also significantly enhances the secretion of pro-inflammatory cytokines, such as TNF-a and IL-6. 23 However, whether dioscin is involved in cell-cell communication by mediating interactions between melanoma cells and macrophages remains unknown. Furthermore, whether the influence of dioscin on TME is related with to effect on Cx43 has yet to be determined. This study investigated the effects of dioscin on TME (including melanoma cells and macrophages) and elucidated the corresponding underlying mechanism. Two classical animal models for metastasis were utilized in vivo, 24, 25 and a Cx43 overexpression and functional deficient cell model was established in vitro. Results showed that dioscin remarkably enhanced the expression and transporting function of Cx43, which consequently decreased the malignancy and metastasis capacity of tumor cells. Dioscin promoted the phagocytic activity and M2-to-M1 transition of Cx43-upregulating macrophages. The function rather than the expression of Cx43 was deemed the vital switch factor for metastatic progression. However, dioscin still exerted significant anti-tumor effects even in Cx43 functional deficient-dependent metastasis. The results of this study suggest that dioscin targets Cx43 to notably alter the phenotype of tumor cells and macrophages in melanoma microenvironment. Therefore, dioscin could serve as a TME-targeting agent for melanoma treatment and relapse prevention.
Material and Methods

Cell lines and reagents
The murine melanoma B16 and RAW264.7, cultured in RPMI 1640 medium (penicillin, 100 U/ml; streptomycin, 100 mg/ml; 10% FBS), were incubated at 378C in 5% CO 2 /well) were planted in 96-well plates, and treated with vehicle (0.1% DMSO) and dioscin (1, 2, 4, 8 mM) for 24, 48, 72 hr. After adding MTT reagent (0.5 mg/ml) for 4 hr incubation, the formazan was dissolved with DMSO. The OD value were read by Victor X3 (PerkinElmer, MA) at 490 nm.
Plasmids construction and transit cell transfection
According to the previous study, the mutated Cx43 plasmid (G21R, c61.G!A) was synthesized. 26 ) cells were seeded in 6-well plates, after incubation for 24 hr, cells were transfected with 3 lg Cx43-LV155 and 3 lg Cx43 G21R plasmids using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Transfectants were incubated in medium containing dioscin (1 and 2 mM) and RA (20 mM) for indicated time and collected for subsequent analysis.
Colony formation assay
B16 cells (300 cells/well) were seeded in 6-well plates, and incubated in the presence of dioscin (1 and 2 mM) or 0.1% DMSO for 14 days. Cells were fixed with 4% paraformaldehyde and stained with crystal violet (0.5%), and the colonies were photographed and counted by ImageJ.
Western blot analysis
B16 cells (2 3 10 5 cells/well) were seeded in 6-well plates, and treated with dioscin (1 and 2 mM) and RA (20 mM) for 48 hr. The protein was centrifuged from cell extraction lysed by RIPA buffer (1% PMSF). According to the standard WB procedure, 27 the blots were incubated with primary antibodies for overnight at 48C. Then after incubated with the corresponding secondary antibodies for 1 hr, the densities of bands were examined by ECL chemiluminescence detection regents (PE, CA).
Quantitative real-time PCR
Total RNA was extracted by TRIzol (Invitrogen, CA) according to the manufacturer's instructions. cDNA was generated by reverse transcription kit (TaKaRa, Dalian, China). SYBR Green real-time PCR were carried out in ABI 7500 fast system (Applied Biosystems, CA). Cx43 forward: 5 0 -ACAGCGG TTGAGTCAGCTTG-3 0 , Cx43 reverse:
Transwell and wound healing assays B16 cells (2 3 10 4 cells/well) were cultured in the upper chamber with low-serum medium contained dioscin and RA, respectively, while high-serum medium (20% FBS) was added to the lower chamber. After 48 hr of incubation at 378C, cells were fixed with 4% paraformaldehyde, and stained with 0.1% crystal violet for 15 min. Then dissolved the crystal violet in DMSO, and the OD value were detected by Victor X3 (PerkinElmer, MA) at 600 nm. For wound healing assays, B16 cells were pretreated with dioscin or RA until 80% confluency, then the plates were scraped in the center of well, and images were taken at 0 and 24 hr using microscope (Leica, Jena, Germany).
MMPs activity assay
According to the standard protocol, we detected MMPs activity by Amplite TM Universal Fluorometric MMP Activity Assay Kit (AAT Bioquest, CA). In brief, B16 cells (2 3 10 5 / well) were seeded in 6-well plate and treated with dioscin (1 and 2 mM) and RA (20 mM) for 48 hr. The supernatant was collected for fluorometric detection.
Immunofluorescence
According to the protocol described previously, 28 the immunofluorescence assays were performed with anti-Cx43 (Abcam, 1:500), anti-E-cadherin and anti-N-cadherin antibodies (Santa Cruz, 1:200), respectively. Incubated with the corresponding PE/FITC conjugated secondary antibodies (Santa Cruz, 1:200), then stained the nucleus with 0.1% DAPI for 30 min, after that, the images were detected by confocal microscopy (Leica, Jena, Germany).
Gap junction dye transport assay
According to the previous study, the Gap junction dye transport assays were performed to assess the function of Cx43. could be detected by confocal confocal microscopy (Leica, Jena, Germany) or FACS Aria III (BD Biosciences, Auckland, New Zealand).
SL/DL assay
According to the previous protocol, the scrape loading/dye transfer (SL/DT) assay were performed to quantify the GJIC. 29 Briefly speaking, the dioscin pretreated B16 cells were washed, scraped and stained with 0.05% lucifer yellow for approximately 1 min. Then then stained cells were rinsed immediately with PBS and fixed by 4% paraformaldehyde. The images were taken by fluorescence microscopy (Leica, Jena, Germany) and distance from the scraped edge to diffused termination of lucifer yellow was quantified by ImageJ.
Flow cytometry analysis
RAW264.7 cells (3.0 3 10 5 /well) were cultured in 6-well plates, and treated with dioscin (1 and 2 mM) and LPS (1 mg/ ml) for 48 hr. According to manufacturer's protocol, suspended cells and incubated with PE-conjugated anti-CD68, PE-cy7-conjugated anti-CD86, PE-conjugated anti-F4/80, Alexa Fluor488-conjugated anti-iNOS, FITC-conjugated anti-CD206 and FITC-conjugated anti-CD209 antibodies, respectively (eBioscience, CA). The fluorescent dyes were detected by FACS Aria III (BD Biosciences, Auckland, New Zealand) and analyzed by Flow Jo 7.6.1 software (Tree Star, Inc., OR).
Co-culture, conditioned medium, and ELISA B16 cells were co-cultured with RAW264.7 cells in the presence of dioscin (1 and 2 mM) or LPS (1 mg/ml) for 48 hr. RAW264.7 cells were stained with DiI (5 mM, red) and B16 cells were stained with CFSE (5 mM, green) for 30 min, respectively. Then RAW264.7 cells were co-cultured with B16 cells with a ratio of 5:1 for another 4 hr and equivalent phase contrast images were taken by confocal microscopy (Leica, Carl Zeiss, Jena, Germany). For phagocytic analysis, B16 cells also co-cultured with RAW264.7 cells transfected with Cx43 and Cx43
G21R for 48 hr. Then, B16 cells were stained with CFSE (green) for 30 min, and images were taken. According to the previous study, 30 RAW264 .7 cells were pretreated with dioscin (1 and 2 mM) and LPS (1 mg/ml) for 48 hr. After change to drug-free medium for 24 hr, the supernatant from RAW264.7 (termed as tumor associated macrophage conditioned medium, TAM-CM) was collected to treat B16 cells for additional 48 hr. According to the manufacturer's instructions, the levels of IL-6, IL-1b, and TNF-a were measured by the corresponding ELISA kits (eBioscience, CA).
Animal experiment
All animal studies were approved by Animal Care and Use Committee (IACUC) in Guangzhou University of Chinese Medicine. Female C57BL/6 mice (6-8 weeks) were purchased from animal center of Guangzhou University of Chinese Medicine. For experimental metastasis model, 24 after 0.2 ml suspended B16 cells (1.5 3 10 6 /ml) were injected (i.v.) into C57BL/6, mice were gavaged with saline and dioscin (30 and 60 mg/kg/day) for 18 days, then the lung tissues were separated from sacrificed mice. For spontaneous metastasis model, 25 we injected (s.c.) B16 cells (2 3 10 6 /mouse) into C57BL/6, then gavaged the mice with saline and dioscin (30 and 60 mg/kg/day). When the tumor volumes reached 1,000 mm 3 , removed the tumor and continually administrated with dioscin by orally gavage mice for another 30 days. At the endpoint, lung tissues and blood were collected for further analysis. Body weight was recorded twice a week.
Statistical analysis
Data were statistical analyzed with SPSS 18.0. *p < 0.05, **p < 0.01, ***p < 0.001 are determined as significance. All the experiments were performed at least in triplicates. Value presented as the means 6 standard deviation (SD) by GraphPad Prism software (GraphPad Software, CA).
Results
Dioscin remarkably inhibited malignancy of B16 melanoma cells
Preliminary MTT results suggested that dioscin significantly suppressed cell proliferation of B16 in a dose-and timedependent manner (Fig. 1a , p < 0.05). Given its accumulated toxicity, dioscin at 1 and 2 mM with respective cell viability of 91.35 6 0.86% and 79.81 6 0.84% at 48 hr were selected for subsequent studies.
Dioscin remarkably inhibited the clonogenic formation ability of B16 cells in a dose-dependent manner (Fig. 1b) . Moreover, wound healing and transwell assays showed that dioscin (1 and 2 mM) dose-dependently reduced the migratory and invasive capacities of B16 melanoma cells (Fig. 1c , p < 0.05). Dioscin at 1 and 2 mM also significantly suppressed the MMP activities by 25.26 6 1.90% and 30.43 6 1.53%, respectively (Fig. 1c, p < 0.05) . Furthermore, dioscin dramatically decreased the expression levels of EMT-associated proteins such as N-cadherin, b-catenin, Snail1, and Vimentin, but increased that of E-cadherin (Fig. 1d, p < 0.01) . Dioscin also dose-dependently inhibited the expression of markers (Sox-2, Oct3/4, and Nanog) for cancer stem cells (CSC) in B16 cells (Fig. 1d , p < 0.05).
Dioscin significantly enhanced the expression and transporting function of Cx43 by activating the retinoid acid (RA) pathway in B16 melanoma cells Cx43, a frequently silenced regulator mediated gap junction communication, its overexpression was reported to effectively suppress tumor proliferation. 31 To further determine the mechanism underlying the anti-melanoma effectiveness of dioscin, the effects of dioscin on Cx43 expression and transporting function were evaluated. Previous study demonstrated that retinoid acid (RA) pathway is attributed to the transcriptional activation of Cx43. 32 Thus, RA, predominant stimulator in RA pathway, was used as a positive control. Dioscin, similar to RA, remarkably increased the gene and protein expression levels of Cx43 compared with the control treatment (Figs. 2a and 2b, p < 0.05). Moreover, immunofluorescence results showed that Cx43 expression was enhanced in cell membrane with increasing dioscin concentrations (Fig.  2c) . A significant dye transfer of Ca-AM was observed in dioscin treated cells (Fig. 2d) . Concurrently, dye transport assay quantified by FACS showed that dioscin at 1 and 2 mM dramatically elevated the dye transfer from donor cells (Ca-
) by 43.99 6 0.67% and 62.75 6 0.15%, respectively (Supporting Information Fig. 1a, p < 0.05 ). In addition, as shown in Fig.  2e , dioscin at 2 mM significantly increased the distance of dye diffusion by 104.5 6 1.09% compared to that in control cells (p < 0.05).
Compared with control treatment, dioscin remarkably altered RA pathway in a dose-dependent manner by increasing the expression levels of RARa, RARb, and RARg while inhibiting that of RXRa in B16 cells (Fig. 2f, p < 0.05) . Compared to other key proteins, the predominant activated factor by dioscin is RARb in RA pathway. Thus, by utilizing pharmacological inhibitor of RARb (LE135, 33 15 mM), we found that when RARb inhibited, dioscin-induced Cx43 upregulation is also significantly abolished (Fig. 2g) . These findings suggested that dioscin, similar to RA, upregulates Cx43 through activation of RA pathway, especially dependent on RARb.
Transporting function of Cx43 is critical in the tumor malignancy of B16 cells
To determine whether the expression or function of Cx43 induced by dioscin is directly related to the metastasis capacity and malignancy of tumor cells, Cx43-LV155 and Cx43
G21R
transduced B16 cells were established. Compared with the Cx43-LV155 plasmid, the Cx43 G21R plasmid, generated by changing nucleotide G to A at position 61, could lead to functional deficiency while still highly expressing Cx43.
After confirming the transfection efficiency (Fig. 3a , p < 0.01), the function of Cx43 was determined through SL/DT assay. As shown in Figure 3b and Supporting Information Figure 1c , after transfected with Cx43 G21R , B16 cells showed a remarkable decrease in the dye coupling incidence within the adjacent cells (79.70%, p < 0.001), indicating that Cx43 G21R mutation exerted a dominant-negative effect on endogenous Cx43-mediated GJIC. Furthermore, Cx43 overexpression significantly inhibited the migratory and invasive abilities of B16 cells by 15.11 6 0.14% and 82.13 6 0.07%, respectively (Fig. 3c, p < 0.05) . By contrast, Cx43 G21R mutation increased these abilities by 37.20 6 0.27% and 84.36 6 0.08%, respectively (Fig. 3c, p < 0.05) . Similarly, the Cx43 overexpression dramatically reduced MMP activities by 39.18 6 1.91%. In Cx43 G21R transfected cells, MMP activities were increased by 31.90 6 2.20% (Fig. 3c , p < 0.05) because of the functional deficiency of Cx43. Simultaneously, the overexpressed Cx43 stimulated the protein expression of epithelial marker (E-cadherin) while suppressed those of mesenchymal markers (N-cadherin, b-catenin, Snail1, and Vimentin) after Cx43-LV155 transfection (Fig. 3d , p < 0.05).
When the transporting function of Cx43 was eliminated, the gene and protein levels of E-cadherin unexpectedly decreased in Cx43 G21R transfected cells. By contrast, the expression levels of mesenchymal markers were enhanced after Cx43 G21R transfection (Fig. 3d , p < 0.05). These results suggest that the transporting function rather than the expression of Cx43 is essential for reversing B16 cell malignancy.
Dioscin dramatically reversed the tumor malignancy of B16 cells, even in nonfunctional Cx43 transfection
Our previous data revealed that dioscin effectively suppressed the invasiveness of B16 cells through upregulating Cx43, whether the anti-metastatic effect of dioscin was dependent on Cx43 was analyzed. As shown in Figure 3b and Supporting Information Figure 1b , dioscin treatment increased the distance of dye diffusion by 45.40%, suggesting the dominant negative effect was attenuated by dioscin-stimulated Cx43 restoration. The effects of dioscin on the migratory and invasive capacities as well as the expression levels of EMT markers in Cx43 and functional deficiency Cx43 G21R transfected cells were analyzed. Dioscin at 2 mM not only continuously inhibited the migration ratio of Cx43-overexpressing B16 cells by 38.63 6 3.12%, but also unexpectedly reversed that of nonfunctional Cx43 cells from increasing by 37.20 6 0.27% to decreasing by 50.51 6 0.06% (Fig. 3c) . The decrease was lower than that of cells with Cx43-LV155. Dioscin significantly decreased the invasion ratio of both Cx43-LV155 and Cx43 G21R transfected cells of 89.52 6 0.06% and 68.62 6 0.12%, respectively (Fig. 3c) . Moreover, dioscin significantly reversed the expression levels of EMT-associated proteins in Cx43 G21R transfected B16 cells. After dioscin treatment, an increase of protein levels of N-cadherin, b-catenin, Snail1, and Vimentin in the Cx43 G21R transfected cells remarkably decreased in a dose-dependent manner. Meanwhile, the suppressed expression of E-cadherin was also remarkably increased (Fig. 3e , p < 0.05).
Dioscin enhanced the phagocytosis of macrophages via inducing Cx43 overexpression
MTT assay was conducted to explore the cytotoxicity of dioscin in RAW264.7 cells. Compared with the control treatment, dioscin did not severely alter the viability of RAW264.7 cells (Fig. 4a) . Dioscin at 1 and 2 mM exerted no visible cytotoxicity at 48 hr and thus was used in the subsequent studies. Compared with the control treatment, dioscin at 1 and 2 mM remarkably increased the protein expression of Cx43 by 95.60 6 0.92% and 128.00 6 1.38%, respectively, in RAW264.7 cells (Fig. 4b, p < To further determine whether dioscin induces M2-to-M1 phenotype transition through Cx43 overexpression or functional enhancement, the phagocytosis of RAW264.7 cells was analyzed under a confocal microscope. Cx43 overexpression significantly enhanced phagocytosis of RAW264.7 cells (1.88-fold of that in mock cells). However, when Cx43 lost transporting function, the phagocytic activity of macrophages showed 0.69-fold decrease in Cx43 G21R transfected RAW264.7 cells (Fig. 4d and Supporting Information Fig.  1d ). Interestingly, dioscin treatment strengthened phagocytotic capacity of 1.76-fold and 2.88-fold in Cx43 overexpressed and nonfunctional Cx43 transfected RAW264.7 cells, respectively.
Dioscin inhibited EMT of B16 cells through promoting the secretion of macrophage related inflammatory cytokines
Given the M1-macrophages secreted IL-1b, TNF-a, and IL-6 and are closely associated with EMT, we confirmed the function of M1 phenotype induced by dioscin. After culturing B16 cells in a conditioned medium, the secretion of IL-1b, TNF-a, and IL-6 were analyzed by ELISA, and EMT capacity of B16 cells was also examined. The medium contained the supernatants produced by RAW264.7 pretreated with dioscin and LPS. The exocytoplasmic expression of IL-1b, TNF-a, and IL-6 were dose-dependently increased by dioscin (Fig.  5a , p < 0.01). Compared with the control cells, dioscinpretreated TAM-CM in RAW264.7 cells remarkably decreased the migratory and invasive capacities of B16 cells. In specific, the supernatants of RAW264.7 cells after pretreatment with 2 mM dioscin significantly decreased the wound healing and transwell ratios of B16 cells by 56.04 6 1.82% and 64.75 6 1.48%, respectively (Fig. 5b, both p < 0.001) . Furthermore, Western blot was used to analyze the protein expression levels of Cx43, EMT-associated proteins, and CSCs markers in B16 cells after treatment with dioscinpretreated TAM-CM. The protein expression levels of Cx43 and E-cadherin in B16 cells were increased, whereas those of Snail1, Vimentin, and N-cadherin were decreased by dioscinpretreated TAM-CM (Fig. 5c, p < 0.05) . Similarly, CSC markers in B16 cells were also remarkably inhibited by dioscin-pretreated TAM-CM after conditional culture (Fig.  5d , p < 0.05).
Dioscin remarkably suppressed tumor growth and metastasis in vivo
To systematically explore the effect of dioscin on melanoma metastasis in vivo, experimental 24 and spontaneous metastasis models, 25 were used in our current animal study (Fig. 6a ). In the spontaneous metastasis model, dioscin treatments (30 and 60 mg/kg) significantly decreased the tumor volumes and tumor weights (Fig. 6b , both p < 0.05) without influencing body weights (Supporting Information Fig. 3a) . Furthermore, dioscin at 30 and 60 mg/kg remarkably reduced the lung metastatic node number of 34.62 6 3.02% and 60.88 6 1.67%, respectively (Fig. 6c , p < 0.05 and p < 0.01). Subsequently, dioscin notably increased the expression levels of E-cadherin and Cx43 but simultaneously decreased that of N-cadherin at tumor tissues (Fig. 6c) .
Similarly, dioscin at 30 or 60 mg/kg exerted no obvious toxicity in experimental metastasis model (Supporting Information Fig. 3b ). However, dioscin at 30 and 60 mg/kg dramatically reduced the metastasis node number was by 36.36 6 2.02% and 70.13 6 1.67%, respectively (Fig. 6d , both p < 0.05). In addition, immunohistochemical results also indicated that dioscin significantly enhanced the abundant of Cx43 and E-cadherin in metastatic tissues (Fig. 6d) . These findings suggest that dioscin processes anti-tumor and antimetastatic potentialities in vivo, and that Cx43 overexpression, which is negatively correlated with EMT-associated markers, is closely related to its antitumor effectiveness.
Consistent with in vitro observations, dioscin remarkably altered RA pathway in vivo by increasing the expression of RARa, RARg while inhibiting that of RXRa either in dorsal tumor or in lung metastatic tissues compared to the adjacent normal tissues (Fig. 6e and Supporting Information Fig. 3c) (Fig. 6f , p < 0.05). Simultaneously, the secretion of TNF-a, IL-1b, and IL-6 was also stimulated by dioscin ( Fig. 6g and Supporting Information Fig. 3d ).
Discussion
Cell-cell communication varies depending on the components of junctions and their dynamic interplay in TME. 34 Cx43, the most predominant gap junction protein expressed in various cells within TME, is critical for cellular homeostasis maintenance processes including cell proliferation, differentiation, and intercellular communication. 35, 36 Although the role of Cx43 in cardiovascular development is well studied, 27 the function and expression of Cx43 in tumorigenesis remain controversial. 27, 31 Our preliminary data suggested that the protein expression of Cx43 was extremely low in B16 melanoma cells (Fig. 2b) or in dorsal tumor tissues and lung metastasis tissues in vivo (Figs. 6c and 6d) .
Dioscin is a natural steroidal saponin prevalent in the Chinese herbal medicine P. zanlanscianense. 22 In our experiment, we find dioscin significantly induced the gene and protein expression level of Cx43 in vitro (Figs. 2b and 2c) . Dioscin also remarkably increased the molecular transporting function of gap junction-mediated intercellular communication (Figs. 2d-2e and Supporting Information Fig. 1a) . Furthermore, corresponding mechanistic studies suggested that overexpression of Cx43 could be attributed to the activation of retinoic acid (RA) signaling pathway. In our present study, dioscin decreased the protein expression of RXRa but increased those of RARa, RARb, and RARg in B16 cells and tumor tissues (Figs. 2f and 6e) . Moreover, antagonists of RARb effectively abolished the effect of dioscin on Cx43 upregulation, suggesting that dioscin-stimulated Cx43 restoration is dependent on the activation of RARb.
Emerging evidence demonstrated that the expression of Cx43 is closely associated with epithelial-mesenchymal transition (EMT) 37 and ultimately promotes tumor progression and metastasis. 38, 39 Some studies reported that EMT is the prerequisite for the acquisition of CSC-like characteristics, and that CSC are consequently necessary for the maintenance of EMT properties. 40 A mechanistic study revealed that the Cx43 can remarkably inhibit the E-cadherin and Sox-2, which are the key biomarkers for EMT and CSCs, respectively, by mediating c-Src/Id1/Sox2 axis. 41 This study showed that dioscin significantly suppressed colony formation ability of B16 melanoma and the migratory and invasive capacities of melanoma cells in vitro (Figs. 1b and 1c) , as well as the tumor growth and metastasis ratio in vivo (Figs. 6b and 6d) . Furthermore, examination of the expression of E-cadherin and N-cadherin revealed that dioscin decreased the potentialities of EMT in vitro (Fig. 1d ) and in vivo (Figs. 6c and 6d ). In addition, dioscin enhanced tumor migratory and invasive abilities in Cx43-overexpressed B16, while reversed that when the function of Cx43 is deficient in Cx43 G21R mutated cells. This suggested that the anti-metastatic effect of dioscin partially depends on Cx43 function. Further conditional knockout or mutated Cx43 animal studies are needed for verifying the target relevance between Cx43 function and dioscin.
Whether the expression or enhanced transporting function of Cx43 is the most predominant factor that contributes to the anti-metastatic effect of dioscin is still unclear. In this study, the overexpressed Cx43 decreased the migratory and invasive abilities of B16 cells in vivo (Fig. 3c) . In addition, the re-expression of Cx43 in melanoma cells significantly suppressed the protein expression levels of EMT biomarkers (Fig. 3d) . By contrast, in Cx43 G21R mutated cells, the EMT capacity of B16 cells was enhanced by Cx43 functional deficiency regardless of its overexpression (Figs. 3c and 3d) . In nonfunctional Cx43 transfected B16 cells, dioscin can still generate a significant increase in expression and transport function of Cx43, and reversion of EMT transition (Supporting Information Figs. 1b, 3b, and 3e) . Particularly, in Cx43 G21R mutation transduced cells, dioscin significantly decreased the migratory ability, even lower than that in control treatment (Fig. 3c) . These might be partially ascribed to the compensation effect of dioscin-stimulated endogenous Cx43 reactivation against dominant-negative effect of Cx43 G21R mutation. Aside from tumor cell, tumor-associated macrophages are significant players in TME, particularly in melanoma microenvironment, where macrophages are the most predominant inflammatory cells. R. J. Anand et al. found that the Cx43 downregulation is directly related to phagocytosis deficiency in macrophages, 11 whereas other studies reported an opposite result. 42 Our results showed that functional deficiency significantly diminished the phagocytic ability of macrophages in vitro (Fig. 4d) . Moreover, dioscin promoted the macrophage polarization from M2 to M1 phenotype without severe cytotoxicity in RAW264.7 cells (Figs. 4a and 4c ) and enhanced their phagocytic ability (Fig. 4d) . Furthermore, dioscin increased Cx43 expression in macrophages in vitro (Fig. 4b) , suggesting that the overexpression and simultaneous enhancement of the transporting function of Cx43 increased phagocytic ability of RAW264.7 cells after dioscin treatment. In mimic TME, dioscin-pretreated TAM-CM demonstrated anti-migratory and anti-invasive activities, as well as suppressed EMT potentiality and CSC percentage (Fig. 5) .
Many commonly used clinical chemotherapeutic agents, such as alkylating agents, spindle poison could severely suppress immune system when kill melanoma cells. [43] [44] [45] Conversely, vemurafenib and dabrafenib, widely used BRAFi against the BRAF mutated melanomas, 46 could transform macrophages from being a passenger to a driver of malignant process, which ultimately result in individualized outcomes and poor prognosis. 20 Therefore, discovering TME targeting agents may provide more therapeutic potentialities against advanced metastatic melanoma. Our present results demonstrated that dioscin could not only inhibit the migration and invasiveness of melanoma cells, but also facilitates the communications between tumor cells and macrophages in TME by overexpressing Cx43 and accelerating its function (Supporting Information Fig. 4 ).
